NorthWest Biotherapeutics Inc (NWBO)

[abeta]

RK - I don't follow this .....

And so if they were responsive to TMZ before progression, the odds are they will be again.

Those odds go up the greater the distance to their last TMZ adjuvant treatment

Is the above referring to:

(a) Control
(b) Control + Progression
(c) Control + Progression + Crossover
(d) Program
(e) All of the above


The trial
------------------
Control ='s

Two intradermal (i.d.) injections of DCVax-L(treatment cohort) or autologous PBMC (placebo cohort) per treatment.

Treatments will be given at days

0,
10,
20,

and at weeks

8,
16,
32,
48,
72,
96 and
120.

So I assume you are talking about "and at weeks"

And therefore - anyone WITHIN the 120 week umbrella may be
experiencing this 2nd time TMZ RESPONSIVENESS .......

This would push us back to - give or take - all patients in the
vicinity of 4/1/2015 and thereafter.

anyway - am I on the right track here ....?

regards

insert-text-here